Ultrasound instrumentation and techniques

Molecular Imaging in Oncology

Volumn , Issue , 2008, Pages 109-119

  Dayton, Paul A ^a   Borden, Mark A ^b  

^a Biomedical Research Imaging Center   (United States)

^b Department of Earth and Environmental Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952803792     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (78)

1. Leighton TG. What is ultrasound? Prog Biophys Mol Biol 2007; 93(1-3):3-83.
2. Leighton TE. The Acoustic Bubble. London: Academic Press, 1994.
3. Bushberg JT, Seibert JA, Leidholdt EM, et al. The essential physics of medical imaging. Baltimore: Williams and Wilkins, 1994.
4. Szabo TL. Diagnostic Ultrasound Imaging: Inside Out. Burlington, Massachusetts: Elsevier Academic Press, 2004.
5. Chomas J, Dayton P, May D, et al. Nondestructive sub-harmonic imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2002; 49(7):883-892.
6. de Jong N, Bouakaz A, Frinking P. Basic acoustic properties of microbubbles. Echocardiography 2002; 19(3):229-240.
7. Mayer S, Grayburn PA. Myocardial contrast agents: recent advances and future directions. Prog Cardiovasc Dis 2001; 44(1):33-44.
8. Dayton PA, Rychak JJ. Molecular ultrasound imaging using microbubble contrast agents. Front Biosci 2007; 12:5124-5142.
9. Chomas JE, Dayton P, May D, et al. Threshold of fragmentation for ultrasonic contrast agents. J Biomed Opt 2001; 6(2):141-150.
10. Bouakaz A, Versluis M, de Jong N. High-speed optical observations of contrast agent destruction. Ultrasound Med Biol 2005; 31(3):391-399.
11. Skyba DM, Price RJ, Linka AZ, et al. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998; 98(4):290-293.
12. Stieger SM, Caskey CF, Adamson RH, et al. Enhancement of vascular permeability with low-frequency contrastenhanced ultrasound in the chorioallantoic membrane model. Radiology 2007; 243(1):112-121.
13. Deng CX, Sieling F, Pan H, et al. Ultrasound-induced cell membrane porosity. Ultrasound Med Biol 2004; 30(4): 519-526.
14. Pollard RE, Sadlowski AR, Bloch SH, et al. Contrast-assisted destruction-replenishment ultrasound for the assessment of tumor microvasculature in a rat model. Technol Cancer Res Treat 2002; 1(6):459-470.
15. Porter TR, Xie F, Kricsfeld A, et al. Noninvasive identification of acute myocardial ischemia and reperfusion with contrast ultrasound using intravenous perfluoropropane-exposed sonicated dextrose albumin. J Am Coll Cardiol 1995; 26(1):33-10.
16. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 2004; 3(6):527-532.
17. Lindner JR. Molecular imaging with contrast ultrasound and targeted microbubbles. J Nucl Cardiol 2004; 11(2): 215-221.
18. Dayton PA, Allen JS, Ferrara KW. The magnitude of radiation force on ultrasound contrast agents. J Acoust Soc Am 2002; 112(5 pt 1):2183-2192.
19. Dayton PA, Morgan KE, Klibanov AL, et al. Optical and acoustical observations of the effects of ultrasound on contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 1999; 46(1):220-232.
20. Becher H, Burns PN. Handbook of Contrast Echocardiog-raphy. Berlin: Springer, 2000.
21. Schneider M. Characteristics of SonoVue (TM). Echocardiogr-J Card 1999; 16(7):743-746.
22. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97(5):473-183.
23. Chomas JE, Dayton P, Allen J, et al. Mechanisms of contrast agent destruction. IEEE Trans Ultrason Ferroelectr Freq Control 2001; 48(1):232-248.
24. Ismail S, Jayaweera AR, Camarano G, et al. Relation between air-filled albumin microbubble and red blood cell rheology in the human myocardium-influence of echocardiographic systems and chest wall attenuation. Circulation 1996; 94(3):445-151.
25. Lindner JR, Ismail S, Spotnitz WD, et al. Albumin micro-bubble persistence during myocardial contrast echocar-diography is associated with microvascular endothelial glycocalyx damage. Circulation 1998; 98(20):2187-2194.
26. Lindner JR. Evolving applications for contrast ultrasound. Am J Cardiol 2002; 90(10A):72J-80J.
27. Lindner JR, Villanueva FS, Dent JM, et al. Assessment of resting perfusion with myocardial contrast echocardiogra-phy: theoretical and practical considerations. Am Heart J 2000; 139(2 pt 1):231-240.
28. Mulvagh SL, DeMaria AN, Feinstein SB, et al. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr 2000; 13(4):331-342.
29. Wei K, Kaul S. Recent advances in myocardial contrast echocardiography. Curr Opin Cardiol 1997; 12(6): 539-546.
30. Forsberg F, Liu JB, Merton DA, et al. Parenchymal enhancement and tumor visualization using a new sonographic contrast agent. J Ultrasound Med 1995; 14(12): 949-957.
31. Goldberg BB, Raichlen JS, Forsberg F. Ultrasound contrast agents: basic principals and clinical applications. London: Martin Dunitz, 2001.
32. Biagi E, Breschi L, Vannacci E, et al. Subharmonic emissions from microbubbles: effect of the driving pulse shape. IEEE Trans Ultrason Ferroelectr Freq Control 2006; 53(11):2174-2182.
33. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000; 35(1):58-71.
34. Ganor Y, Adam D, Kimmel E. Time and pressure dependence of acoustic signals radiated from microbubbles. Ultrasound Med Biol 2005; 31(10):1367-1374.
35. Postema M, Schmitz G. Bubble dynamics involved in ultrasonic imaging. Expert Rev Mol Diagn 2006; 6(3): 493-502.
36. Sun Y, Kruse DE, Ferrara KW. Contrast imaging with chirped excitation. IEEE Trans Ultrason Ferroelectr Freq Control 2007; 54(3):520-529.
37. Wu J, Pepe J, Dewitt W. Nonlinear behaviors of contrast agents relevant to diagnostic and therapeutic applications. Ultrasound Med Biol 2003; 29(4):555-562.
38. Frinking PJ, Cespedes EI, Kirkhorn J, et al. A new ultrasound contrast imaging approach based on the combination of multiple imaging pulses and a separate release burst. IEEE Trans Ultrason Ferroelectr Freq Control 2001; 48(3): 643-651.
39. Deng CX, Lizzi FL, Kalisz A, et al. Study of ultrasonic contrast agents using a dual-frequency band technique. Ultrasound Med Biol 2000; 26(5):819-831.
40. Eckersley RJ, Tang MX, Chetty K, et al. Microbubble contrast agent detection using binary coded pulses. Ultrasound Med Biol 2007; 33(11):1787-1795.
41. Burns PN. Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996; 51(1):50-55.
42. Forsberg F, Goldberg BB, Liu JB, et al. On the feasibility of real-time, in vivo harmonic imaging with proteinaceous microspheres. J Ultrasound Med 1996; 15(12):853-860; quiz 61-2.
43. Frinking PJ, Bouakaz A, Kirkhorn J, et al. Ultrasound contrast imaging: current and new potential methods. Ultrasound Med Biol 2000; 26(6):965-975.
44. Schwarz KQ, Chen X, Steinmetz S, et al. Harmonic imaging with Levovist. J Am Soc Echocardiogr 1997; 10(1):1-10.
45. Forsberg F, Shi WT, Goldberg BB. Subharmonic imaging of contrast agents. Ultrasonics 2000; 38(1-8):93-98.
46. Krishna PD, Shankar PM, Newhouse VL. Subharmonic generation from ultrasonic contrast agents. Phys Med Biol 1999; 44(3):681-694.
47. Shi WT, Forsberg F, Hall AL, et al. Subharmonic imaging with microbubble contrast agents: initial results. Ultrason Imaging 1999; 21(2):79-94.
48. Bouakaz A, Frigstad S, Ten Cate FJ, et al. Super harmonic imaging: a new imaging technique for improved contrast detection. Ultrasound Med Biol 2002; 28(1):59-68.
49. Bouakaz A, Krenning BJ, Vletter WB, et al. Contrast superharmonic imaging: a feasibility study. Ultrasound Med Biol 2003; 29(4):547-553.
50. Kruse DE, Ferrara KW. A new imaging strategy using wideband transient response of ultrasound contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 2005; 52(8): 1320-1329.
51. Zhao S, Kruse D, Ferrara K, et al. Selective imaging of adherent targeted ultrasound contrast agents. Phys Med Biol 2007; 52:2055-2072.
52. Kook SH, Kwag HJ. Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions. J Clin Ultrasound 2003; 31(5):227-238.
53. Villanueva FS, Gertz EW, Csikari M, et al. Detection of coronary artery stenosis with power Doppler imaging. Circulation 2001; 103(21):2624-2630.
54. de Jong N, Frinking PJ, Bouakaz A, et al. Detection procedures of ultrasound contrast agents. Ultrasonics 2000; 38(1-8):87-92.
55. Morgan KE, Allen JS, Dayton PA, et al. Experimental and theoretical evaluation of microbubble behavior: effect of transmitted phase and bubble size. IEEE Trans Ultrason Ferroelectr Freq Control 2000; 47(6):1494-1509.
56. Eckersley RJ, Chin CT, Burns PN. Optimising phase and amplitude modulation schemes for imaging microbubble contrast agents at low acoustic power. Ultrasound Med Biol 2005; 31(2):213-219.
57. Mor-Avi V, Caiani EG, Collins KA, et al. Combined assessment of myocardial perfusion and regional left ventricular function by analysis of contrast-enhanced power modulation images. Circulation 2001; 104(3):352-357.
58. Phillips P, Gardner E. Contrast-agent detection and quantification. Eur Radiol 2004; 14(suppl 8):P4-P10.
59. Brock-Fisher GA. Inventor contrast agent imaging with suppression of nonlinear tissue response. US patent 6,361,498 B1, 2002.
60. Phillips PJ. Contrast pulse sequences (CPS): imaging nonlinear microbubbles. In: Proceedings of the 2001 IEEE Ultrasonics Symposium, 2001; 2:1739-1745.
61. Zhao S, Kruse DE, Ferrara KW, et al. Acoustic response from adherent targeted contrast agents. J Acoust Soc Am 2006; 120(6):EL63-EL69.
62. Zhao S, Borden M, Bloch SH, et al. Radiation-force assisted targeting facilitates ultrasonic molecular imaging. Mol Imaging 2004; 3(3):135-148.
63. Rychak JJ, Klibanov AL, Hossack JA. Acoustic radiation force enhances targeted delivery of ultrasound contrast microbubbles: in vitro verification. IEEE Trans Ultrason Ferroelectr Freq Control 2005; 52(3):421-433.
64. Rychak JJ, Klibanov AL, Ley KF, et al. Enhanced targeting of ultrasound contrast agents using acoustic radiation force. Ultrasound Med Biol 2007; 33(7):1132-1139. [Epub 2007 Apr 18].
65. Borden MA, Martinez GV, Ricker J, et al. Lateral phase separation in lipid-coated microbubbles. Langmuir 2006; 22(9):4291-1297.
66. Borden MA, Zhang H, Gillies RJ, et al. A stimulus-responsive contrast agent for ultrasound molecular imaging. Biomaterials 2008; 29(5):597-606.
67. Stephens DN, Ming Lu X, Proulx T, et al. Multi-frequency array development for drug delivery therapies: characterization and first use of a triple row ultrasound probe. In: Proceedings of the 2006 IEEE Ultrasonics Symposium 2006:66-69, doi:10.1109/ULTSYM.2006.30.
68. Demirci U, Ergun AS, Oralkan O, et al. Forward-viewing CMUT arrays for medical imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2004; 51(7):887-895.
69. Pemberton J, Li X, Karamlou T, et al. The use of live three-dimensional Doppler echocardiography in the measurement of cardiac output: an in vivo animal study. J Am Coll Cardiol 2005; 45(3):433-138.
70. Albrecht H, Stroszczynski C, Felix R, et al. Real time 3D (4D) ultrasound-guided percutaneous biopsy of solid tumours. Ultraschall Med 2006; 27(4):324-328.
71. Voormolen MM, Krenning BJ, van Geuns RJ, et al. Efficient quantification of the left ventricular volume using 3-dimensional echocardiography: the minimal number of equiangular long-axis images for accurate quantification of the left ventricular volume. J Am Soc Echocardiogr 2007; 20(4):373-380.
72. Torigian DA, Huang SS, Houseni M, et al. Functional imaging of cancer with emphasis on molecular techniques. CA Cancer J Clin 2007; 57(4):206-224.
73. Atri M. New technologies and directed agents for applications of cancer imaging. J Clin Oncol 2006; 24(20):3299-3308.
74. Alavi A, Lakhani P, Mavi A, et al. PET: a revolution in medical imaging. Radiol Clin North Am 2004; 42(6): 983-1001, vii.
75. Weller GE, Wong MK, Modzelewski RA, et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide argininearginine-leucine. Cancer Res 2005; 65(2):533-539.
76. Korpanty G, Carbon JG, Grayburn PA, et al. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res 2007; 13(1):323-330.
77. Heppner P, Lindner JR. Contrast ultrasound assessment of angiogenesis by perfusion and molecular imaging. Expert Rev Mol Diagn 2005; 5(3):447-455.
78. Leong-Poi H, Christiansen J, Klibanov AL, et al. Non-invasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation 2003; 107(3):455-460.